Last edition
News about
First Use of Kyverna KYV-101 in Patients with Progressive Multiple Sclerosis Published
Kyverna Therapeutics, Inc. has announced about a recent report published in Med that describes the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in two patients suffering from progressive multiple sclerosis (MS).
FDA Approves Medtronic's Evolut FX+ Transcatheter Aortic Valve Replacement System
With a modified diamond-shaped frame design, the Evolut FX+ offers larger coronary access windows, providing increased space for catheter maneuverability to reach coronary arteries of varying patient anatomies.
FDA Clears PATHFAST hs-cTnI-II Test for Rapid Myocardial Infarction Diagnosis at Point of Care
Prompt diagnosis is crucial in treating patients suspected of having a heart attack.
Akebia Gains FDA Approval of Vafseo Tablets for Treatment of Anemia
Akebia Therapeutics has declared that the US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults.
Integral Molecular Gains ISO 9001 Certification for its MPA Services
Integral Molecular has secured IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array (MPA) specificity testing services.
<br />
Greenway Health and DrFirst to Harness Automation Tech to Boost Medication Adherence
Greenway Health has formed a strategic partnership with DrFirst to use the power of automation technology to reduce prescription abandonment and improve medication adherence.
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume.
PhotoPharmics Launches Largest Phototherapy Trial for Parkinson's Disease
The 'Celeste Light for PD Trial' (found at lightforpd.com) represents a significant stride in Parkinson’s disease (PD) treatment, leveraging innovative Spectramax™ technology through the passive and non-invasive Celeste® phototherapy device.
Lightpoint Performs World's First Bladder Cancer SLN Procedure with SENSEI
Lightpoint Surgical Ltd., an affiliate of Telix Pharmaceuticals Ltd. has achieved a new milestone with world’s first bladder cancer sentinel lymph node (SLN) procedure with SENSEI
INOVIO Plans to Participate in The Novel Therapeutics Forum at Penn Medicine
INOVIO has announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy